Oncotelic Therapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Oncotelic Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $170.4 thousand for the year ending 2023.

  • Oncotelic Therapeutics, Inc. showed a decrease of -29.4% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from Oncotelic Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on April 12, 2024.
  • XBRL data for this metric is available from 2008 to 2023 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2008 to 2023), Oncotelic Therapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 99.1%.
  • Historical annual values: Fiscal year 2023: $170.4 thousand | Fiscal year 2022: $241.5 thousand | Fiscal year 2021: $568.8 thousand | Fiscal year 2020: $474.0 thousand | Fiscal year 2019: $82.0 thousand | Fiscal year 2018: $2.5 thousand | Fiscal year 2017: $1.12 million | Fiscal year 2016: $3.54 million | Fiscal year 2015: $27.29 million | Fiscal year 2014: $30.03 million | Fiscal year 2012: $4.95 million | Fiscal year 2011: $9.97 million | Fiscal year 2010: $4.60 million | Fiscal year 2009: $13.93 million | Fiscal year 2008: $18.28 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: